AERIE PHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$290.4M

571 transactions

Summary

AERIE PHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $38.1MSales: $222.7M51 insiders

Date	Insider	Type	Value
2022-11-21	KANNAN RAJ(Chief Executive Officer)	D	$3.3M
2022-11-21	KANNAN RAJ(Chief Executive Officer)	D	$2.8M
2022-11-21	KANNAN RAJ(Chief Executive Officer)	D	$1.3M
2022-11-21	Lang Peter Frederick(Chief Financial Officer)	D	$1.0M
2022-11-21	LaRocca John(General Counsel)	D	$817K
2022-11-21	LaRocca John(General Counsel)	D	$425K
2022-11-21	Calabrese Jeffrey(Vice President of Finance)	D	$283K
2022-11-21	Croarkin Richard	D	$245K
2022-11-21	du Toit Michael	D	$245K
2022-11-21	GRYSKA DAVID W	D	$175K
2022-11-21	Croarkin Richard	D	$154K
2022-11-21	du Toit Michael	D	$154K
2022-11-21	GRYSKA DAVID W	D	$154K
2022-11-21	Calabrese Jeffrey(Vice President of Finance)	D	$143K
2022-11-21	Croarkin Richard	D	$120K
2022-11-21	GRYSKA DAVID W	D	$30K
2022-11-21	Calabrese Jeffrey(Vice President of Finance)	D	$26K
2022-11-21	Croarkin Richard	D	$15K
2022-11-21	du Toit Michael	D	$15K
2022-11-21	GRYSKA DAVID W	D	$15K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

AERIE PHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope